Triumeq and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Triumeq (abacavir sulfate; dolutegravir sodium; lamivudine) and Claritin (loratadine). Common drug interactions include anhedonia among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Triumeq and Claritin. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Triumeq?

Triumeq has active ingredients of abacavir sulfate; dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 6,900 Triumeq users. Check the latest studies of Triumeq.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

On Jul, 09, 2026

44 people who take Triumeq and Claritin together, and have interactions are studied.

What are the common drug interactions of Triumeq and Claritin, by gender? *:

female:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Emotional distress
Pain
Tooth loss
Osteonecrosis (death of bone)
Abdominal discomfort
Arthralgia (joint pain)
Bone loss

male:

Emotional distress
Pain
Nausea (feeling of having an urge to vomit)
Osteopenia (a condition where bone mineral density is lower than normal)
Dizziness
Chronic kidney disease
Hospitalisation
Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
Suicidal ideation
Back pain

What are the common drug interactions of Triumeq and Claritin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Diarrhoea
Insomnia (sleeplessness)

30-39:

Gamma-glutamyltransferase increased
Hyperbilirubinaemia (excess of bilirubin in the blood)
Pyoderma (any skin disease that is pyogenic)
Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)
Nausea (feeling of having an urge to vomit)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased
Emotional distress
Pain

40-49:

Anxiety
Dizziness
Emotional distress
Pain
Chronic kidney disease
Fatigue (feeling of tiredness)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Nephrolithiasis (calculi in the kidneys)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)

50-59:

Bone density decreased
Emotional distress
Fatigue (feeling of tiredness)
Multiple fractures
Nausea (feeling of having an urge to vomit)
Radius fracture
Rash
Tooth loss
Abdominal discomfort
Arthralgia (joint pain)

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 12 people, 27.27%
Diarrhea: 10 people, 22.73%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 22.73%
Allergic Rhinitis: 10 people, 22.73%
Pain: 6 people, 13.64%
High Blood Pressure: 6 people, 13.64%
Hypersensitivity: 5 people, 11.36%
Inflammation: 3 people, 6.82%
Headache (pain in head): 3 people, 6.82%
Enlarged Prostate: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Triumeq and Claritin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously